Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1996 1
1997 1
2003 1
2005 1
2018 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Impact on testicular function of a single ablative activity of 3.7 GBq radioactive iodine for differentiated thyroid carcinoma.
Bourcigaux N, Rubino C, Berthaud I, Toubert ME, Donadille B, Leenhardt L, Petrot-Keller I, Brailly-Tabard S, Fromigué J, de Vathaire F, Simon T, Siffroi JP, Schlumberger M, Bouchard P, Christin-Maitre S. Bourcigaux N, et al. Among authors: de vathaire f, rubino c. Hum Reprod. 2018 Aug 1;33(8):1408-1416. doi: 10.1093/humrep/dey222. Hum Reprod. 2018. PMID: 29912343
These studies would be required before sperm banking should be suggested for all patients. However, sperm preservation for DTC patients who require cumulative radioiodine activities higher than 3.7 GBq should be proposed. STUDY FUNDING/COMPETING INTEREST(S): …
These studies would be required before sperm banking should be suggested for all patients. However, sperm preservation for DTC patien …
Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.
Rubino C, Adjadj E, Doyon F, Shamsaldin A, Abbas TM, Caillou B, Colonna M, Cecarreli C, Schvartz C, Bardet S, Langlois C, Ricard M, Schlumberger M, de Vathaire F. Rubino C, et al. Among authors: de vathaire f. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1084-9. doi: 10.1016/j.ijrobp.2004.12.063. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990012
PURPOSE: In thyroid cancer patients, radioiodine treatment has been shown to be associated with an increased risk of colon carcinoma. The aim of this study in thyroid cancer patients was to evaluate the role of familial factors in the risk of co …
PURPOSE: In thyroid cancer patients, radioiodine treatment has been shown to be associated with an increased risk of co …
Second primary malignancies in thyroid cancer patients.
Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M. Rubino C, et al. Among authors: de vathaire f. Br J Cancer. 2003 Nov 3;89(9):1638-44. doi: 10.1038/sj.bjc.6601319. Br J Cancer. 2003. PMID: 14583762 Free PMC article.
The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to assess since the number of thyroid cancer patients treated at each centre is limited. The risk of second primary malignancies (SP …
The late health effects associated with radioiodine ((131)I) given as treatment for thyroid cancer are difficult to ass …
Leukaemias and cancers following iodine-131 administration for thyroid cancer.
de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiére E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H. de Vathaire F, et al. Br J Cancer. 1997;75(5):734-9. doi: 10.1038/bjc.1997.130. Br J Cancer. 1997. PMID: 9043033 Free PMC article.
We studied 1771 patients treated for a thyroid cancer in two institutions. None of these patients had been treated with external radiotherapy and 1497 had received (131)I. ...When digestive tract cancers were excluded, the overall excess relative risk of seco …
We studied 1771 patients treated for a thyroid cancer in two institutions. None of these patients had been treated with extern …
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C. Schlumberger M, et al. Among authors: de vathaire f. J Nucl Med. 1996 Apr;37(4):598-605. J Nucl Med. 1996. PMID: 8691248 Free article.
We assessed the therapeutic benefits of 131I treatment in patients with distant metastases of differentiated thyroid carcinoma. METHODS: Of 2200 patients treated for differentiated thyroid carcinoma at our institution, 394 had lung and/or bone metastases. ...CONCLUS …
We assessed the therapeutic benefits of 131I treatment in patients with distant metastases of differentiated thyroid carcinoma. METHO …
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.
Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso J, Caillou B, Parmentier C. Schlumberger M, et al. Among authors: de vathaire f. J Clin Endocrinol Metab. 1986 Oct;63(4):960-7. doi: 10.1210/jcem-63-4-960. J Clin Endocrinol Metab. 1986. PMID: 3745409
They were extensive metastases, older age at discovery of the metastases, absence of radioiodine uptake by the metastases, and moderately differentiated follicular cell type. ...Our results suggest that the aim of management should be to detect and treat metastases in pati …
They were extensive metastases, older age at discovery of the metastases, absence of radioiodine uptake by the metastases, and modera …